Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,485,705
+$517,944 QoQ
Shares Held
841,445
+3.9% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Dec 31, 2021CallValue
$6,672,000
CallShares
400,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Deep Track Capital, LP holds $4,185,471,777 across 55 Biotechnology names. BBIO ranks #23 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
11,526,971 | $286,329,959 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,600,000 | $252,540,000 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,873,000 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
4,279,848 | $206,288,673 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
1,100,000 | $185,922,000 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,532,374 | $182,337,406 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $166,742,808 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
4,106,067 | $165,187,075 |
All Filings in BBIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,485,705 | 841,445 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $61,967,761 | 810,142 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $62,328,000 | 1,200,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,862,000 | 900,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $96,796,000 | 2,800,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,477,805 | 819,162 | Shares | Sole | 2025-02-14 | |
| 2021-12-31 | $6,672,000 | 400,000 | Call | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||